1

Ipca Laboratories

#3399

Rank

$4.27B

Marketcap

IN India

Country

Ipca Laboratories
Leadership team

Mr. Premchand Godha A.C. A., B. Com., CA (Chairman, CEO & MD)

Mr. Ajit Kumar Bhanwarlal Jain (CFO, Joint MD & Exec. Director)

Mr. Harish P. Kamath (Compliance Officer, Corp. Counsel & Company Sec.)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Mumbai, Maharashtra, India
Established
1949
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
IPCALAB.NS
Social Media
Overview
Location
Summary
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
History

Ipca Laboratories was founded by Dr. UD Karnik in 1949 to produce hematinic tonics. Over the next two decades, the company expanded its product portfolio and added both active pharmaceutical ingredients (APIs) and formulations to its offerings. In 1994, Ipca became a public company and listed its shares on the Bombay Stock Exchange. Since then, the company has grown its presence in the international markets and established itself as one of the leading Indian pharmaceutical companies.

Mission
Ipca's mission is to improve the quality of life of patients & to continually develop and deliver quality, affordable and innovative products and services.
Vision
Ipca's vision is to be a leader in providing superior quality and affordable medications & healthcare products empowering people to live healthier lives.
Key Team

Mr. Pranay Godha (Exec. Director)

Mr. Prashant Premchand Godha (Exec. Director)

Mr. Vishnu Saran Singh Kushwaha (VP of Technical)

Mr. Pawan Kothari (VP of Operations)

Mr. Sunil Ghai (Pres of Marketing)

Mr. Sameer S. Tamhane (Sr. VP of HR)

Dr. Ashok Kumar (Pres of R&D - Chemicals)

Recognition and Awards
Ipca Laboratories has won numerous awards and recognition, including the Frost & Sullivan “Best Pharmaceutical Company in India” award in 2013 and the “Excellence in R&D” award at the Pharma Leaders 2016 Awards.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Ipca Laboratories
Leadership team

Mr. Premchand Godha A.C. A., B. Com., CA (Chairman, CEO & MD)

Mr. Ajit Kumar Bhanwarlal Jain (CFO, Joint MD & Exec. Director)

Mr. Harish P. Kamath (Compliance Officer, Corp. Counsel & Company Sec.)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Mumbai, Maharashtra, India
Established
1949
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
IPCALAB.NS
Social Media